Dr Kosiborod has served as a consultant or on an advisory board for 35Pharma, Alnylam, Amgen, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Dexcom, Eli Lilly, Esperion Therapeutics, Janssen, Lexicon Pharmaceuticals, Merck (Diabetes and Cardiovascular), Novo Nordisk, Pfizer, Pharmacosmos, Sanofi, scPharmaceuticals, Structure Therapeutics, Vifor Pharma, and Youngene Therapeutics
Kompozcia je zaloen na centrlnom geometrickom vzore kvetu ivota, ktor predstavuje zkladn stavebn blok vesmru a vetkch ivch bytost
40 weeks) and ATTAIN-1 (obesity
Akkermansia muciniphila 167 million AFU +